US$ 27.99
glp-1 news 2025 october 16 Weight-Loss Drug Demonstration Begins July 2026 What's next for GLP-1 innovation:
Description
Hazard ratio (HR) and 95% confidence intervals (CI) of incident and recurrent CUD were calculated for 12-month follow-up by comparing propensity-score matched patient cohorts

Weight regain and cardiometabolic effects after withdrawal of semaglutide: The STEP 1 trial extension
:max_bytes(150000):strip_icc()/health-GettyImages-2025836701-ce3f5ccf0f98428e9d14abaeb07ba307.jpg)
Cognitive performance in idiopathic intracranial hypertension and relevance of intracranial pressure

[DOI] [PubMed] [Google Scholar] 206.Anastasiou I, et al
It helps regulate appetite, slows gastric emptying, and supports blood sugar control
